AstraZeneca, Oxford resume stage-three U.K. trials of potential coronavirus vaccine
Professor of surgery at John Hopkins School of Medicine Dr. Marty Makary weighs in on ‘Fox Report.’
A volunteer...
Five years ago, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and National Cancer Institute (NCI), part of the National Institutes of Health, jointly launched a very different kind of cancer study....
The electronic health record giant Epic will use the InterSystems IRIS Data Platform beginning with the August release of its EHR, the Cambridge, Massachusetts-based technology provider announced this...
Patient satisfaction with telehealth services has been increasing during the COVID-19 pandemic, but hurdles are still in place, a J.D. Power report released Thursday found.
According to its 2020 U.S. Telehealth...
Scientists at Fred Hutchinson Cancer Research Center believe they’ve found a better of use of mobile technology to help adult cigarette smokers quit.
In a large clinical trial published in JAMA...
In response to increasing patient demand for telehealth, Kaiser Permanente this week announced the launch of a new “virtual-first” healthcare plan in Washington state.
The plan, which will...
An experimental medication slows the progression of the neurodegenerative disease called Amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, according to recently released results from...
The US has begun late stage clinical trials into a drug formulated to fight COVID-19, officials said Tuesday.
The medicine is an antibody against the new coronavirus called LY-CoV555, which was identified...
DirectTrust has made the draft of its new Trusted Instant Messaging+ standard available for testing. It bills TIM+ as the industry-first standard to enable real-time secure healthcare IMs by incorporating...
Children have specific and unique medical needs – and software supporting their care should be tailored to help address those needs.
So the Office of the National Coordinator for Health IT has published...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok